Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats by Grijalva, James et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
Cardiovascular Diabetology
Open Access Original investigation
Exercise training enhanced myocardial endothelial nitric oxide 
synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats
James Grijalva, Steven Hicks, Xiangmin Zhao, Sushma Medikayala, 
Pawel M Kaminski, Michael S Wolin and John G Edwards*
Address: Department of Physiology, New York Medical College, Valhalla NY, USA
Email: James Grijalva - JAMES_GRIJALVA@nymc.edu; Steven Hicks - hickss@upstate.edu; Xiangmin Zhao - XIANGMIN_ZHAO@nymc.edu; 
Sushma Medikayala - Sushma_Medikayala@nymc.edu; Pawel M Kaminski - PAWEL_KAMINSKI@nymc.edu; 
Michael S Wolin - MIKE_WOLIN@nymc.edu; John G Edwards* - j_edwards@nymc.edu
* Corresponding author    
Abstract
Background: Different mechanisms of diabetic-induced NO dysfunction have been proposed and
central to most of them are significant changes in eNOS function as the rate-limiting step in NO
bioavailability. eNOS exists in both monomeric and dimeric conformations, with the dimeric form
catalyzing the synthesis of nitric oxide, while the monomeric form catalyzes the synthesis of
superoxide (O2
-). Diabetic-induced shifts to decrease the dimer:monomer ratio is thought to
contribute to the degradation of nitric oxide (NO) bioavailability. Exercise has long been useful in
the management of diabetes. Although exercise-induced increases expression of eNOS has been
reported, it is unclear if exercise may alter the functional coupling of eNOS.
Methods: To investigate this question, Goto-Kakizaki rats (a model of type II diabetes) were
randomly assigned to a 9-week running program (train) or sedentary (sed) groups.
Results: Exercise training significantly (p < .05) increased plantaris muscle cytochrome oxidase,
significantly improved glycosylated hemoglobin (sed: 7.33 ± 0.56%; train: 6.1 ± 0.18%), ad improved
insulin sensitivity. Exercise increased both total eNOS expression and the dimer:monomer ratio in
the left ventricle LV (sed: 11.7 ± 3.2%; train: 41.4 ± 4.7%). Functional analysis of eNOS indicated
that exercise induced significant increases in nitric oxide (+28%) production and concomitant
decreases in eNOS-dependent superoxide (-12%) production. This effect was observed in the
absence of tetrahydrobiopterin (BH4), but not in the presence of exogenous BH4. Exercise training
also significantly decreased NADPH-dependent O2
- activity.
Conclusion: Exercise-induced increased eNOS dimerization resulted in an increased coupling of
the enzyme to facilitate production of NO at the expense of ROS generation. This shift that could
serve to decrease diabetic-related oxidative stress, which should serve to lessen diabetic-related
complications.
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Background
In the management of diabetes there is considerable evi-
dence to demonstrate the benefits of exercise including
improved glycemic control, an increased quality of life,
and a reduction of cardiovascular risk factors. Exercise
with and without dietary changes resulted in a significant
reduction in glycosylated hemoglobin (HbA1c), increased
insulin sensitivity, improved blood lipid levels, and low-
ered blood pressure [1,2]. Even low intensity forms of
exercise such as walking will benefit NIDDM patients [1].
Exercise induces angiogenesis and altered vasculature
reactivity in different vascular beds [3,4]. Exercise
increases the sensitivity to endothelium-dependent relax-
ation by acetylcholine, but not the endothelium-inde-
pendent response to sodium nitroprusside [3]. Chronic
exercise increases NO production as early as one week
after the start of training [4]. These changes are thought to
be the result of increased eNOS protein [5,6]. Training
effects may be limited to the vasculature of the working
muscles; no effect was observed in mesenteric arterioles,
suggesting that exercise-induced increases in stress may
have be the responsible mechanism [7]. Several groups
have reported that shear stress induces increases in eNOS
expression [8,9]. However, studies in both diabetic
patients and in diabetic animals have yielded different
results; that vascular beds not participating in the
response to exercise demonstrate significant improve-
ments, suggesting that mechanisms other than localized
stimuli are important [10,11].
Nitric oxide (NO) signaling regulates vascular tone, inhib-
its components of the atherogenic process, and influences
myocardial energy consumption [12,13]. NO synthesis is
governed by nitric oxide synthase (NOS). Three isoforms
of NOS have been identified which are the products of
three separate genes; endothelial NOS (eNOS), inducible
NOS (iNOS), and neuronal NOS (nNOS). These isoforms
share about 50–60% sequence identity and all use L-
arginine, O2, and NADPH to catalyze the synthesis of
NADP, citrulline, and NO as well as superoxide. Structural
domain studies of the NOS molecule have identified sep-
arate oxygenase and reductase domains [14]. Dimeriza-
tion is a requirement for catalytic activity of eNOS,
although the truly active form is a complex that includes
calmodulin, FAD, tetrahydrobiopterin (BH4), and iron
protoporphyrin IX (haem) [14]. The dimeric form cata-
lyzes the rate-limiting step in the synthesis of nitric oxide,
while the monomeric form catalyzes the synthesis of O2
-,
a highly reactive oxidant species (ROS) [15]. The products
catalyzed by eNOS are subject to complex regulation that
we are just now beginning to understand. NO is an auto-
crine factor that regulates myocardial functioning via mul-
tiple mechanisms [16]. More recently Zhang et.al
demonstrated that exercise training was associated with
increased myocardial eNOS levels and enhanced myocar-
dial contractility [17].
Different mechanisms of diabetic-induced NO dysfunc-
tion have been proposed and central to most of them are
significant changes in eNOS function as the rate-limiting
step in NO bioavailability. Several studies have reported
decreased eNOS activity/protein levels in diabetic patients
or animal models of diabetes [18-20]. The composition of
the eNOS complex is critical for the relative formation of
NO or superoxide formation. The mechanisms responsi-
ble for eNOS dysfunction remain unclear, however, a
decrease in the dimer to monomer eNOS ratio within the
myocardium of diabetic animals has been reported [15].
Although exercise-induced increases in eNOS expression
have been documented, it is unclear if exercise may also
alter the functional coupling of eNOS. To investigate this
question, Goto-Kakizaki rats, a model of NIDDM, were
exercise trained, to test if chronic exercise could improve
eNOS function and enhance NO bioavailability.
Methods
Training Protocol
Twenty male GK rats were randomly assigned to exercise
training (train) or sedentary (sed) groups. Rats were run
on a motor driven treadmill set at a ten-degree incline.
Animals were initially run at approximately 50% VO2max
and the animals were run for up to 60 minutes and 5 days/
week for 9 weeks. While training, animals were closely
monitored to ensure animal safety and training compli-
ance. Experimental protocols had institutional approval
and animals were maintained in accordance with APS's
Guiding Principles in the Care and Use of Animals and the
Guide for the Care and Use of Laboratory Animals.
Glucose Tolerance Test
Following an overnight fast, animals were injected with
Nembutal (40 mg/kg i.p.). To perform the glucose toler-
ance test, sterile glucose (1.0 g glucose/kg i.p.) was
injected into the abdominal cavity and tail vein blood
sampled at selected intervals. Insulin was determined
from plasma samples by ELISA (Crystal Chem, Downers
Grove, IL). Following the glucose tolerance test, animals
were given additional Nembutal (100 mg/kg i.p.) and sac-
rificed for tissue harvest.
Low Temperature (LT) Electrophoresis and Western Blot 
Analysis
Tissues were stored at -80°C until used. LV samples were
homogenized in ice-cold buffer (20 mM HEPES pH7.5,
50 mM NaCl, 1% SDS, 1× protease inhibitor (Sigma-
Aldrich, P-8340). Protein concentration was determined
by the Bradford method (BioRad reagent). LT electro-
phoresis is an in vitro test to determine the ratio of dimer-
ized and monomerized forms of eNOS, with an increaseCardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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in this ratio reflective increased coupling of the eNOS
enzyme. For LT electrophoresis, samples were mixed with
Lamelli buffer (without β-mercaptoethanol except where
noted), before samples were loaded onto a 7.5% SDS-
PAGE and electrophoresis was performed at 4°C. For total
eNOS determinations, samples were mixed with Lamelli
buffer, heated to 95°C for 5 min, and loaded onto a 7.5%
SDS-PAGE and electrophoresis was perform at room tem-
perature. The gels were blotted onto Hybond-P (Amer-
sham Biosciences, Piscataway NJ) by a semi-dry transfer
protocol. Western analysis was performed as described
previously [21]. Antibodies used included eNOS (BD
Transduction, San Jose, CA) and alpha-MHC derived from
the BA-G5 cell line (ATCC, Manassas, VA). Antibody bind-
ing was visualized using the Amersham ECL Plus kit. Band
density was quantified using AlphaEaseFC software
(AlphaInnotech, San Leando CA). The dimer:monomer
ratio calculated from band densities: % Dimerized eNOS
= {dimer density/(dimer density + monomer den-
sity)}*100. Values presented are mean ± SEM.
eNOS Activity
eNOS enzyme activity was determined by fluorescence
spectroscopy method, using 2,3-diaminonaphthalene
(DAN), and modified from that described by Misko et.al.
[22]. In brief, LV was homogenized in ice-cold buffer (20
mM HEPES-pH 7.4, 0.1 mM EDTA, 1 mM glutathione, 10
μM BH4, 1× proteinase inhibitor. The homogenate was
centrifuged at 1000 × g for 10 minutes at 4°C, and the
supernatant retained for protein determination. To meas-
ure activity; 100 μg protein was incubated in reaction
buffer (30 μM arginine, 1 μM FAD, 0.5 mM NADPH, 50
nM calmodulin). The reaction mixture was incubated for
3 hours at 37°C before the addition of acidified DAN. Flu-
orescence was determined using a Kontron SFM 25 spec-
trofluorometer (excitation 365 nm; emission 450 nm).
eNOS specific activity was the difference in fluorescence
between CaCl2 and calcium-free EGTA buffered solutions.
To determine this, separate reactions were performed in
the presence of 1 mM CaCl2 or 0.5 mM EGTA and the dif-
ference taken as eNOS specific activity. To examine the
role of BH4 the reactions were also performed in the pres-
ence or absence of 7.5 μM BH4. Nitrite formation was cal-
culated from standards using sodium nitrite. Using 750
nM 7-nitroindazole (a nNOS specific inhibitor) prelimi-
nary experiments indicated that nNOS did not contribute
to left ventricular calcium-dependent NOS activity (data
not shown). Values presented are mean ± SEM of arbitrary
fluorescent units.
Superoxide Activity
Superoxide activity was determined by two methods. In
brief, LV was homogenized in ice-cold buffer (20 mM
HEPES-pH 7.4, 0.1 mM EDTA, 1 mM glutathione, 10 μM
BH4, 1× proteinase inhibitor. Protein concentration was
determined by the Bradford method. NADPH oxidase
activity, using 5 μM lucigenin, was determined as we have
previously described [23]. NOX-dependent activity was
determined by the addition of 300 μM apocynin. eNOS
dependent superoxide activity was determined using
dihydroethidium (DHE), as described by Zhao et.al. [24]
To measure eNOS-driven superoxide activity, separate
solutions containing either 10 μM BH4 or vehicle were
added to reaction buffer (30 μM arginine, 1 μM FAD, 0.5
mM NADPH, 1 mM CaCl2, 50 nM calmodulin). 200 μg
protein was incubated at 37°C and the development of
fluorescence measured using an Infinite M200 plate
reader (Tecan, Research Triangle Park, NC) (excitation;
480 nm, emission; 573 nm). Values presented are mean ±
SEM of normalized arbitrary optical density (OD) units.
Cytochrome Oxidase Assay
Cytochrome oxidase activity was determined as previ-
ously described [21]. The rate of cytochrome C oxidation
was followed at 550 nm (ε = 21.0 mM-1 cm-1), using an
Ultrospec 3100 spectrophometer (Amersham Biosciences,
Piscataway NJ).
RNA Analysis
Total RNA from left ventricle was isolated using a FAS-
TRNA ProGreen Kit (Q-Biogene, Irvine CA). Quantifica-
tion of mRNA levels was done by QRT-PCR by real-time
fluorescent using a Stratagene MX3000p as described pre-
viously [21]. The following genes were studied: αMHC
(f;5'-CTACAAGCGCCAGGCTGAGG-3' ; r; 5'-GTGGGAT-
AGCAACAGCGAGGC-3'), NADPH Oxidase 1 (f; 5'-
TCCTCACTGGCTGGGATAGC-3' ; r; 5'-TTGAGTACCGC
CGACAGCAT-3'), NADPH Oxidase 2 (f; 5'-TTGAGTGGT-
TCGCAGACCT-3' ; r; 5'-GTTGGGCCGTCCATACAG-3'),
p47 (f; 5'-ATCCCAACTACGCAGGTGAA-3'; r;5'-TATCTC-
CTCCCCAGCCTTCT -3'), GTP cyclohydrolase (f; 5'-AAG-
GGTCCATATTGGTTATCTTCCT-3' ; r; 5'-ACACCTCGCAT
GACCATACA-3'), eNOS (f; 5'-GGCATACAGAACCCAG-
GATGG-3'; r; 5'-GCAGGCTGCAGTCCTTTGAT-3'), β-actin
(f; 5'-GCGGTGACCATAGCCCTCTTT-3'; r; 5'-TGCCACTC
CCAAAGTAAAGGGTCA-3'). The data was normalized by
Δ2Ct method using β-actin, and the fidelity of the reac-
tions was verified by melting point analysis. Data pre-
sented are the mean ± SEM with respect to sedentary
control values. β-actin expression was compared to
hypoxanthine phosphoribosyltransferase (HPRT) another
"housekeeping" gene and no differences were observed.
Statistical analysis
Statistical analyses were performed using NCSS Software
(NCSS, Kaysville UT). Where appropriate, student t-test or
ANOVA was utilized; post-hoc analysis was done using a
Fisher's LSD analysis. Values presented are mean ± SEM,
and statistical significance was set at p < .05.Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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Results
Plantaris muscle cytochrome oxidase enzyme activity, a
marker of aerobic metabolism and peripheral training
adaptations was significantly increased following 9 weeks
of training in the diabetic rats compared to sedentary con-
trols (Table 1). Similarly, training significantly increased
left ventricular weight (sedentary: 0.72 ± 0.02, train; 0.80
± 0.01 g), while body weights were unaltered (Table 1).
We have previously reported that high intensity exercise
will increase left ventricular α-MHC [21]. In the present
study using a lower intensity of exercise training, we did
not observe a change in left ventricular α-MHC protein
(sedentary; 100 ± 6.2%, Train; 100 ± 5.4%) or α-MHC-
mRNA levels. Increases in skeletal muscle cytochrome oxi-
dase activity and left ventricular weights are both indica-
tive of training adaptations to endurance exercise.
The exercise trained GK rats had a significant decrease in
fasting blood glucose and consistent with this, a signifi-
cant decrease in HbA1c (Table 1). Exercise has been useful
in the management of diabetes in obese models of
NIDDM, in part due to improved handling of blood glu-
cose levels. To determine if training altered the sensitivity
to glucose, a glucose tolerance test was performed. A sig-
nificant decrease in the area under the curve analysis
(AUC) in the trained animals was observed compared to
sedentary animals (Figure 1). Plasma insulin levels were
determined prior to the start of the glucose tolerance test
and after 120 minutes. Fasting levels were significantly
lower in the trained animals compared to sedentary ani-
mals (Table 1). Calculation of an insulin sensitivity index
as described by Matsuda and DeFronzo, determined that
exercise training significantly increased insulin sensitivity
(Table 1) [25].
Exercise training has been reported to increase eNOS pro-
tein in different tissues [5,6]. Consistent with those find-
ings, we observed a significant increase in left ventricular
total eNOS (Figure 2). Dimerization of eNOS is required
for the synthesis of NO and nitric oxide, and a decrease in
the dimer:monomer eNOS ratio has been reported in dia-
betic myocardium [15]. When low temperature electro-
phoresis was performed under nonreducing conditions,
we found that the ratio of dimer:monomer eNOS was also
significantly increased by exercise training (Figure 2).
When the samples were treated with 0.2% β-mercaptoeth-
anol and low temperature electrophoresis was performed,
the ratio of dimer:monomer eNOS was compressed but
still significantly increased (sed: 17.8 ± 1.4%; train: 28.5 ±
4.1%). In most studies changes in eNOS have only been
observed in those tissues undergoing exercise-induced
increases in blood flow. In the present study total kidney
eNOS levels tended to be increased, but a high level of var-
iance blunted the statistical evaluation (sed; 100 ± 11.1%;
train: 151.5 ± 22.3%: p = 0.06). However, a significant
increase in the dimer:monomer ratio was observed in the
eNOS protein from kidney (sed: 12.0 ± 1.7%; train: 20.7
± 2.9%). Thus exercise training increased dimerization of
eNOS in both tissues.
Increased dimerization of the eNOS protein should shift
its enzymatic activity towards improved NO generation, at
the expense of superoxide production. To examine this
concept, two in vitro determinations of eNOS function
were made. In the absence of exogenous BH4, exercise
training significantly increased eNOS activity compared to
sedentary controls (Figure 3A). The addition of exogenous
BH4 to the reaction buffer significantly increased eNOS
activity in both groups, but canceled the differences
between the groups. Determination of eNOS-driven
superoxide generation found that in the absence of added
BH4, exercise training resulted in significantly decreased
superoxide production compared to the sedentary group
(Figure 3B). The addition of BH4 to the reaction media
decreased eNOS-driven superoxide generation in both
groups and no difference between sedentary and exercise
trained groups were observed. Exercise training also sig-
nificantly decreased ventricular NADPH oxidase activity
(Figure 4). In the presence of the NADPH oxidase inhibi-
tor apocynin, NADPH oxidase activity was significantly
decreased only in the sedentary group and the differences
between sedentary and trained groups were eliminated.
Table 1: Morphometric and Blood Parameter Data
Body mass LV/BW Plantaris Cytochrome Oxidase Fasting Glucose Fasting insulin 120 Insulin ISI HbA1c
(g) nmole/min/mg (mg%) (ng/ml) (ng/ml) (%)
Sedentary 384 1.86 0.31 205.3 2.57 4.56 16.6 7.36
± 7 ± 0.05 ± 0.02 ± 9.5 ± 0.27 ± 0.66 ± 1.60 ± 0.56
Exercise Trained 374 2.15 0.39 173.6 1.46 3.77 29.3 6.16
± 5 ± 0.04 ± 0.05 ± 9.5 ± 0.17 ± 0.59 ± 4.5 ± 0.16
ns p < .05 p < .05 p < .05 p < .05 ns p < .05 p < .05Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
Page 5 of 12
(page number not for citation purposes)
The apparent shift in NADPH oxidase activity suggests
that this enzyme complex is either less active or that exer-
cise decreased expression of the constitutive subunits.
However, when expression of three subunits (NOX1,
NOX2, and p47) was examined no significant changes in
the relative mRNA levels were observed between the sed-
entary and exercised trained groups. Similarly, expression
of GTP cyclohydrolase, the rate limiting step in BH4 syn-
thesis, was unaltered by exercise training. In contrast to
increased levels of eNOS protein, exercise training did
cause a significant decrease in eNOS-mRNA levels (Figure
5).
Discussion
Even low intensity forms of exercise such as walking have
been shown to benefit NIDDM levels, and patients [1].
Exercise lowers HbA1c, increases insulin sensitivity,
improves blood lipid levels, and lowers blood pressure in
diabetic individuals [1,2]. Exercise-induced increases in
tissue eNOS expression have been reported and our
results in the heart are consistent with those findings. The
major finding of this study was that exercise training
increased eNOS function, in part by an increase in dimer-
ization, as one mechanism for increasing NO bioavaila-
bility in the diabetic heart.
GK rats have elevated fasting glucose (150–250 mg%), are
hyperinsulinemic at a young age, have impaired response
to glucose, and increased HbA1c [26]. As a model of type
2 diabetes, the GK rats do not have the confounding fac-
tors of hyperlipidemia or hypercholesterolemia observed
in obese-diabetic rats. The etiology of the GK rats is
unknown, but it has been suggested that impaired pancre-
atic mitochondrial function may partially explain the
depressed insulin release [27]. GK rats display symptoms
associated with diabetic complications, including reduced
nerve conduction velocity indicative of peripheral neu-
ropathy [28]. Progressive renal involvement in GK rats
presents in a manner similar to NIDDM in humans; that
includes thickening of the glomerular basement mem-
brane [29]. Similar to others, we have also found endothe-
lium-dependent microvascular dysfunction in the GK rats
(data not shown) [26,30,31]. GK animals also display
increases in oxidative stress markers and susceptibility to
lipid peroxidation in the hearts of older (12–18 months)
but not younger (3–6 months) animals [32].
Exercise training decreased LV eNOS-mRNA levels Figure 5
Exercise training decreased LV eNOS-mRNA levels. Total LV RNA was isolated and quantification of mRNA 
levels was done by QRT-PCR as described in Methods. Data was normalized by the Δ2Ct method using β-actin, and the 
fidelity of the reactions was verified by melting point analysis. Values presented are % control mean ± SEM of 10 animals per 
group; * p < .05 compared control.Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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Exercise improves glucose tolerance in the GK rats Figure 1
Exercise improves glucose tolerance in the GK rats. Sedentary and exercise trained GK rats were anesthetized and 
then injected with 1.0 g/kg glucose as described in Methods. A. Tail blood glucose wad determined at select intervals. B. Area 
under the curve analysis was performed using the NCSS software. Values are mean ± SEM of 10–14 animals; * p < .05 com-
pared to control.Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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Exercise-induced increases in vascular eNOS protein have
been known for sometime [5,6,33]. More recently, it has
been shown that exercise will also alter myocardial eNOS
protein and phosphorylation status [17]. Zhang et.al exer-
cise trained rats by a 10 week swimming program [17].
They demonstrated that exercise increased myocardial
NOx production, eNOS protein levels, and increased the
sensitivity to insulin-stimulated phosphorylation of
eNOS. The shift in eNOS phosphorylation (ser1179) sta-
tus was mediated through the Akt signaling pathway and
resulted in enhanced myocardial contractility [17]. Shifts
in phosphorylation status do not fully explain our find-
ings of increased eNOS dimerization. eNOS has 5 phos-
phorylation sites; serines 116, 617, 635, 1179 and
threonine 497 (bovine coordinates). Whereas phosphor-
ylation of the serines 617, 635 and 1179 will activate
eNOS, the Thr497 phosphorylation appears to serve as an
intrinsic switch to enhance coupling of eNOS in favor of
NO production at the expense of superoxide [34]. To date
no one has reported exercise-induced alterations in eNOS-
Thr497 phosphorylation status. Fulton et al demonstrated
that phosphorylation of ser1179 was not required for cor-
rect intracellular localization [35]. eNOS differs from
iNOS and nNOS in that the former contains the consen-
sus sequences for both myristoylation and palmitoyla-
tion. Myristoylation is required for initial targeting of
Exercise training increased eNOS protein levels and eNOS dimerization Figure 2
Exercise training increased eNOS protein levels and eNOS dimerization. Total protein from the left ventricle was 
prepared and electrophoresis under normal or low temperature conditions were carried out as described in Methods. A. 
Quantitative analysis of eNOS expression. Values are mean ± SEM of 6–10 animals per group; * p < .05 compared to control. 
B. Representative western blots of eNOS protein.
A. 
 B. Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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Exercise training enhances eNOS function in the absence of BH4 Figure 3
Exercise training enhances eNOS function in the absence of BH4. A. eNOS activity was measured using in the 
absence or present of BH4. B. eNOS-dependent superoxide formation was measured as described in Methods. Values are 
mean ± SEM of 10 animals per group; # p < .05 compared to respective control, * p < .05 compared to respective -BH4 assay 
group.Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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eNOS to the cell membrane, while palmitoylation may
stabilize the eNOS membrane association [36,37]. To
date no one has reported exercise-induced changes in
myristoylation or palmitoylation. However, the extent of
site specific phosphorylation is modified by subcellular
localization and hence stimulus specific activation that is
dependent upon localization would be a useful avenue
for future work [38].
Exercise improved the eNOS coupling state; a shift that
could serve to decrease diabetic-related oxidative stress
and lessen diabetic-related complications. Two in vitro
determinations of eNOS function were made. Both meas-
ures were influenced by the addition of exogenous BH4 to
the reaction. eNOS coupling was greater in the left ventri-
cle from the exercise trained group only in the absence of
exogenous BH4. This suggests that BH4 may have been
more tightly bound to eNOS in the trained group or eNOS
had an increased sensitivity to residual BH4, producing a
shift in eNOS functional state.
BH4 is both an anti-oxidant and an essential cofactor of
eNOS and other members of the monooxygenase family
[39]. In both healthy individuals and diabetics, a single
oral glucose challenge can reduce NO-specific vasodilata-
tion, an action that was blocked by supplementation with
tetrahydrobiopterin (BH4) [40-42]. Although the exact
mechanism of its actions are not clear, it is thought that
BH4 stabilizes the dimer conformation and facilitates L-
arginine binding as the first step in its conversion to citrul-
line [43,44]. Shifts in BH4 concentration directly influence
the rate of NO or superoxide anion O2
-  production
[39,45,46]. Both IDDM and NIDDM animal models have
reported decreased concentrations of BH4 in the vascula-
ture [47,48]. Differential effects of BH4 have also been
observed with exercise in aged humans. Eskura et.al dem-
onstrated that BH4 supplementation improved vasodilata-
tion in sedentary but not exercise trained elderly humans,
suggesting that chronic exercise improved BH4 bio-availa-
bility in that population [49]. We have demonstrated that
exercise training improved eNOS function when BH4 may
Exercise training decreased LV superoxide generation Figure 4
Exercise training decreased LV superoxide generation. LV homogenates were prepared as described in Methods to 
determine superoxide generation. Activity was assay in a Krebs-HEPES buffer using 5 μM lucigenin, 200 μM NADPH and in the 
absence or presence of 300 μM apocynin. Values are mean ± SEM cpm/mg protein of 10 animals per group; # p < .05 com-
pared to respective control, * p < .05 compared to respective -BH4 assay group.Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
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have been limiting. This suggests that chronic exercise
enhanced eNOS function, in part through altered BH4
bioavailability.
We observed that exercise training reduced apocynin-sen-
sitive chemiluminescence, indicative of a decrease in
NAD(P)H oxidase activity in the left ventricle. Apocynin is
thought to interfere with p47 activation of NAD(P)H oxi-
dase, but more recently has also been suggested to act as
an antioxidant [50,51]. If this latter mechanism was oper-
ational, we should have observed some decreases in both
sedentary and training groups. However no differences
were observed in the exercise trained group suggesting
that chronic exercise modified the NAD(P)H oxidase
complex activity. Plasma levels of angiotensin II (Ang II)
are elevated in diabetics with poor glucose control and in
untreated diabetic animal models [52-55]. Conversely,
normalization of Ang II levels can be achieved with
improved glucose handling or ACE inhibition [52,56].
Chronically elevated Ang II levels are associated with
increased expression of NAD(P)H oxidase components
and oxidative stress [56]. We did not observe changes in
NOX 1, NOX 2, or p47-mRNA levels suggesting that
altered expression was not influenced by training and that
a shift in the activation of NADPH oxidase may have had
a greater role in the observed improvements. ROS pro-
motes oxidation of BH4 to dihydropterin and one conse-
quence of decreased NAD(P)H oxidase activity may be to
improve BH4 bioavailability [57].
Control of eNOS protein levels is a complex operation
that is mediated on several levels including eNOS tran-
scription, mRNA stability, and post-translational modifi-
cations. We have made the paradoxical observation that
exercise training of diabetic animals lead to an increase in
eNOS protein, but also a decrease in eNOS-mRNA. This
outcome is the reverse observed by others who found that
in comparison to controls, diabetes decreased eNOS pro-
tein but increased eNOS-mRNA [18,58]. Similarly, in cul-
tured endothelial cells, elevated glucose levels increased
eNOS-mRNA [59]. This paradox may be explained in part
by diabetic-induced decreases in eNOS function which
Exercise induced alterations in the diabetic myocardium leading to improvements in eNOS function Figure 6
Exercise induced alterations in the diabetic myocardium leading to improvements in eNOS function. 
; decrease in level or inhibition of function,  ; increase in level or improvement of function. Improvements 
derived from increased insulin sensitivity are from the findings of Zhang et.al. [17].Cardiovascular Diabetology 2008, 7:34 http://www.cardiab.com/content/7/1/34
Page 11 of 12
(page number not for citation purposes)
activates compensatory mechanisms. Drummond et.al.
demonstrated that exogenous H2O2 increased eNOS tran-
scription and eNOS-mRNA stability [60]. Our observa-
tion that exercise training decreased both eNOS-driven
and NADPH oxidase derived ROS should serve to lessen
this driving force for eNOS transcription. Second, hyperg-
lycemia acts as a NO scavenger and the exercise-induced
improvements in glycemic control should improve NO
bioavailability [61]. Third, increased NO bioavailability is
known to serve as a negative feedback mechanism to
decrease eNOS transcription via a cGMP-mediated path-
way [62,63]. Thus the decrease in eNOS-mRNA may have
been the result of the decreased driving forces for eNOS
transcription.
Summary
Regulation of eNOS function is showing itself to be an
increasingly complex event that diabetes clearly disrupts.
Exercise-induced increases in eNOS expression have been
demonstrated in several reports as well as exercise-
induced shifts of eNOS phosphorylation status. The major
findings of this study are that exercise at least partially
reversed diabetic-induced eNOS dysfunction through
increased dimerization leading to increased NO genera-
tion at the expense of superoxide production. As shown in
Figure 6, it is likely that this was achieved through several
distinct mechanisms that converge on the management of
cellular ROS and BH4 metabolism.
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